Publications en collaboration avec des chercheurs de Consiglio Nazionale delle Ricerche (24)

2022

  1. Endovascular administration of magnetized nanocarriers targeting brain delivery after stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 42, Núm. 2, pp. 237-252

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Reactive astrocyte nomenclature, definitions, and future directions

    Nature Neuroscience, Vol. 24, Núm. 3, pp. 312-325

2020

  1. Nesfatin-1 decreases the motivational and rewarding value of food

    Neuropsychopharmacology, Vol. 45, Núm. 10, pp. 1645-1655

2017

  1. CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal

    Biological Psychiatry, Vol. 81, Núm. 7, pp. 625-634

2016

  1. Astrocytes as secretory cells of the central nervous system: Idiosyncrasies of vesicular secretion

    EMBO Journal, Vol. 35, Núm. 3, pp. 239-257

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

2012

  1. Astroglial excitability and gliotransmission: An appraisal of Ca2+ as a signalling route

    ASN Neuro, Vol. 4, Núm. 2, pp. 103-119

  2. In vivo veritas, in vitro artificia

    Trends in Molecular Medicine

2010

  1. An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness

    Immunity, Vol. 33, Núm. 6, pp. 929-941

2009

  1. A model of ischemia-induced neuroblast activation in the adult subventricular zone

    PLoS ONE, Vol. 4, Núm. 4

2007

  1. P2 receptor antagonist trinitrophenyl-adenosine-triphosphate protects hippocampus from oxygen and glucose deprivation cell death

    Journal of Pharmacology and Experimental Therapeutics, Vol. 323, Núm. 1, pp. 70-77

  2. Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus

    British Journal of Pharmacology, Vol. 151, Núm. 7, pp. 1109-1116

2005

  1. The metabotropic P2Y 4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells

    Neurobiology of Disease, Vol. 18, Núm. 1, pp. 100-109

2004

  1. Role of the metabotropic P2Y4 receptor during hypoglycemia: Cross talk with the ionotropic NMDAR1 receptor

    Experimental Cell Research, Vol. 300, Núm. 1, pp. 149-158

  2. Synaptic P2X7 and Oxygen/Glucose Deprivation in Organotypic Hippocampal Cultures

    Journal of Cerebral Blood Flow and Metabolism, Vol. 24, Núm. 4, pp. 392-398

2003

  1. Up-regulation of P2X2, P2X4 receptor and ischemic cell death: Prevention by P2 antagonists

    Neuroscience, Vol. 120, Núm. 1, pp. 85-98

2002

  1. Cerebellar lesion up-regulates P2X1 and P2X2 purinergic receptors in precerebellar nuclei

    Neuroscience, Vol. 115, Núm. 2, pp. 425-434

  2. Extracellular ATP and nerve growth factor intensify hypoglycemia-induced cell death in primary neurons: Role of P2 and NGFRp75 receptors

    Journal of Neurochemistry, Vol. 83, Núm. 5, pp. 1129-1138

  3. P2 receptor modulation and cytotoxic function in cultured CNS neurons

    Neuropharmacology, Vol. 42, Núm. 4, pp. 489-501